Israel Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
February 11, 2015
134 Pages - SKU: BMI5466949
Countries covered: Israel

Israel Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Israel offers an attractive pharmaceutical market, with the government committed to developingthe public healthcare system. An improving intellectual property regime and high penetration of patentedmedicines will be seen as positive by innovative drugmakers. Risks to our outlook include politicaluncertainty and the fiscal deficit, which pose a risk to the government's planned healthcare expenditure.

Headline Expenditure Projections

Pharmaceuticals: ILS7.51bn (USD2.10bn) in 2014 to ILS7.82bn (USD2.06bn) in 2015; +4.16% in localcurrency terms and -1.9% in US dollar terms.

Healthcare: ILS78.62bn (USD21.98bn) in 2014 to ILS83.62bn (USD22.01bn) in 2015; +6.4% in localcurrency terms and +0.1% in US dollar terms.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Israel Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Israel Q4 2014 by BMI Research
Pharmaceuticals and Healthcare Report - Israel Q4 2014BMI View: Even though Israel's tense domestic and external situation threatens overall market stability, itspharmaceutical industry remains well ...
The Pharmaceutical Market: Israel by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Israel (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Israel reports

D&B Country Report: Israel by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!